Dr Sarah Garner is a pharmacist specialising in health technology assessment (HTA) and has provided technical advice to NICE since 2000. Sarah is also on the recently formed Regulation of Medicines Review Panel, which carries out independent reviews of UK licensing authority decisions. Her Harkness research will focus on low-value medical interventions in the context of value-based insurance design. This is a progression from the work on NHS disinvestment that she has been coordinating in her role as associate director for research and development at NICE.